Therapeutic advances in pruritus as a model of personalized medicine
Pruritus or itch is a sensation that evolved to protect humans and other vertebrates against environmental irritants, parasitic infestations and disease-borne insects. However, in the setting of chronic skin inflammation and other medical conditions, pruritus can become pathologic and chronic in nature; indeed, chronic pruritus is defined as itch that persists for greater than 6 weeks and significantly impairs the quality of life of patients. It also poses a major therapeutic challenge. However, recent advances in itch biology have led to the development of novel therapies. This review highlights how new innovations in anti-pruritic medications are revolutionizing the treatment of chronic pruritus and leading to new paradigms of personalized medicine.
Authors
- Kelsey Auyeung
- Brian Kim (ORCID: https://orcid.org/0000-0002-8100-7161)
- Ramsey Kubofcik
Institutions
- Allen Institute for Brain Science (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1111/jdv.70169
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of Diabetes and Digestive and Kidney Diseases